Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
CLGN
#3898
CollPlant Biotechnologies Ltd Ordinary Shares
0.5
7
-1.72%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
-1.72%
Monthly Change
-70.62%
6 month change
-79.86%
Cambio anual
-83.71%
Cierres anteriores
0.5
8
Open
0.5
7
Bid
Ask
Low
0.5
7
High
0.5
7
Volumen
1
Markets
Acciones
Atención Sanitaria
CLGN
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q4, 24
TTM
Key stats
Total common shares outstanding
11.45 M
44.87 M
Valuation ratios
Enterprise value
29.33 M
345.14 M
Price to earnings ratio
—
—
Price to sales ratio
—
—
Price to cash flow ratio
—
—
Price to book ratio
3.06
12.77
Enterprise value to EBITDA ratio
—
—
Profitability ratios
Return on assets %
—
—
Return on equity %
—
—
Return on invested capital %
—
—
Gross margin %
—
—
Operating margin %
—
—
EBITDA margin %
—
—
Net margin %
—
—
Liquidity ratios
Quick ratio
4.29
37.03
Current ratio
4.44
38.21
Inventory turnover
—
—
Asset turnover
—
—
Solvency ratios
Debt to assets ratio
—
—
Debt to equity ratio
—
—
Long term debt to total assets ratio
—
—
Long term debt to total equity ratio
—
—
Per share metrics
Operating cash flow per share
—
—
EBIT per share
—
—
EBITDA per share
—
—
Total debt per share
—
—
Cash per share
1.04
7.17
Net current asset value per share
1.15
10.25
Tangible book value per share
1.16
10.29
Working capital per share
0.89
9.17
Book value per share
1.18
10.36
Noticias
CollPlant secures Korean patent for dermal filler technology
CollPlant lance le kit de bioencre BioFlex pour la bioimpression 3D
CollPlant launches BioFlex bioink kit for 3D bioprinting
La notation des actions CollPlant dégradée à "Conserver" contre "Acheter" par D. Boral Capital
CollPlant stock rating downgraded to Hold from Buy by D. Boral Capital
CollPlant Biotechnologies convoque une assemblée annuelle et extraordinaire pour le 31 décembre
CollPlant Biotechnologies schedules annual and extraordinary meeting for December 31
Le BPA de Collplant ADR a manqué les attentes de 0,41$, le CA en dessous des prévisions
Collplant ADR earnings missed by $0.41, revenue fell short of estimates
Les actions de CollPlant en légère baisse, le chiffre d’affaires du T3 inférieur aux prévisions
CollPlant shares edge down as Q3 revenue falls short of estimates
CollPlant étend sa distribution en Amérique du Nord avec un nouveau hub logistique